title: The isolation and physiology of inhibin and related proteins.
abstract: Inhibin, a glycoprotein that preferentially suppresses follicle-stimulating hormone (FSH) secretion, has been isolated from follicular fluid as a heterodimer of two dissimilar subunits linked by disulphide bonds. The larger subunit is termed alpha and the smaller is designated beta. Two forms of inhibin termed A and B have been isolated, the differences being due to variations in the amino acid sequence of the beta-subunit; Inhibin A consists of alpha-beta and Inhibin B of alpha-beta B. Dimers of the beta-subunit, termed activins, have also been found in follicular fluid; these stimulate pituitary FSH secretion. Inhibin is produced in the female by the granulosa cell and corpus luteum under the control of FSH and luteinizing hormone (LH), respectively. The levels in serum rise to peak at mid-cycle and in the mid-luteal phase of the human menstrual cycle, and decline prior to menstruation. In pregnancy, the late-luteal phase decline in inhibin does not occur and the levels increase slowly. Studies suggest that the levels in pregnancy arise from an embryonic source, particularly the placenta. In the male, inhibin is produced by the Sertoli cells under the control of FSH by mechanisms involving cyclic adenosine 3', 5'-monophosphate. Testosterone exerts a minor inhibitory control at supraphysiological levels (10(-5) M), but human chorionic gonadotropin stimulation results paradoxically in a rise in serum inhibin levels. Disruption of spermatogenesis in the rat by cryptorchidism, heat treatment, or efferent duct ligation results in a decline in inhibin levels and a rise in FSH levels, findings consistent with the negative feedback action of inhibin on FSH secretion. As well as their roles in the reproductive system, inhibin and activin have more widespread actions in the haemopoietic, immune and nervous systems as evidenced by the finding of mRNA for its subunits in a range of tissues. Other studies have shown actions on erythroid differentiation and on mitotic activity in thymocytes. These actions suggest that inhibin and activin may function as growth factors as well as regulators of FSH.
authors.affiliation: Department of Anatomy, Monash University, Melbourne, Victoria, Australia.
authors.forename: D M
authors.initials: DM
authors.lastname: de Kretser
authors.forename: D M
authors.initials: DM
authors.lastname: Robertson
mesh_terms: D000818:Animals; D003338:Corpus Luteum / Q000378:metabolism; D005260:Female; D005640:Follicle Stimulating Hormone / Q000037:antagonists & inhibitors; D006107:Granulosa Cells / Q000378:metabolism; D006801:Humans; D007265:Inhibins / Q000032:analysis / Q000235:genetics / Q000302:isolation & purification* / Q000502:physiology; D008297:Male; D006080:Ovarian Follicle / Q000032:analysis* / Q000378:metabolism; D011247:Pregnancy; D012708:Sertoli Cells / Q000378:metabolism; D013737:Testis / Q000032:analysis* / Q000378:metabolism
chemical_list: D007265:Inhibins; D005640:Follicle Stimulating Hormone